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Highlights 
 A DiCre recombinase-based system for inducible expression in 
Leishmania major is presented. 
 The system is dose and time dependent  
 The system mediates the expression of target genes from both 
integrated and episomal contexts  
 
Abstract 
 Here we present the establishment of an inducible system based on the 
dimerizable Cre recombinase (DiCre) for controlled gene expression in the protozoan 
parasite Leishmania. Rapamycin-induced DiCre activation promoted efficient flipping 
and expression of gene products in a time and dose-dependent manner. The DiCre 
flipping activity induced the expression of target genes from both integrated and 
episomal contexts broadening the applicability of the system. We validated the 
system by inducing the expression of both full length and truncated forms of the 
checkpoint protein Rad9, which revealed that the highly divergent C-terminal domain 
of Rad9 is necessary for proper subcellular localization. Thus, by establishing the 
DiCre-based inducible system we have created and validated a robust new tool for 
assessing gene function in Leishmania. 
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The genus Leishmania encompasses over 20 species, including those that 
are the causative agents of devastating human diseases worldwide collectively called 
leishmaniasis [1]. The Leishmania genome is organized in directional gene clusters 
that may include hundreds of genes from which transcription occurs in a polycistronic 
fashion. No canonical RNA Pol II promoters have been identified in this parasite and 
gene expression regulation seems to have been devolved to post-transcriptional 
processes [2]. The remarkable genome plasticity of Leishmania, which leads to 
frequent genome rearrangements, not only impacts gene expression control, but also 
hinders the genetic manipulation of the parasite [3,4]. Therefore, a dependable and 
robust genetic toolkit is necessary for effective post-genomic functional studies in this 
protozoan.  
Over the past decades, a collection of genetic manipulation tools for 
Leishmania has been introduced. For instance, transient and stable transfection, 
gene replacement and disruption, expression vectors and functional 
complementation and rescue are well-established and reliable tools [5–7]. More 
recently, the introduction of protein stabilization strategies [8,9] a tetracycline-
inducible system for protein expression [10], the dimerizable Cre recombinase 
(DiCre)-based system for inducible knockouts [11,12] and the establishment of 
CRISPR cas9 genome editing [13] has further improved our capacity to address 
peculiar aspects of this parasite’s biology. Given the stringent regulation of DiCre 
recombinase activity and the variety of strategies for genetic regulation conferred by 
the use of loxP recombination sites [14,15], we decided to adapt the DiCre-based 
inducible system for controlled gene expression in Leishmania major. Our strategy 
involves the generation of a cell line constitutively expressing DiCre recombinase and 
carrying an inverted gene of interest flanked by cis orientated loxP sites. These 
constructs are integrated into the 18S rRNA locus and expressed under the control of 
the Pol I promoter. The antisense orientation of the gene of interest prevents 
transcription of coding RNA from the positive strand until activation of DiCre 
recombinase activity by rapamycin treatment. Once activated, DiCre catalyzes the 
‘flip’ of the sequence flanked by cis loxP sites, resulting in transcription of a coding 
RNA and subsequent protein expression (Figure S1A). To prevent continual gene 
‘flipping’ by loxP site recombination we employed left-element mutant (lox66) and 
right-element mutant (lox77) sites [16]. These mutated lox sequences act as sites of 
recombination to generate a wild-type loxP site and a double mutant Lox72 site for 
which DiCre has a dramatically reduced affinity. As such, a single recombination 
event is favoured upon DiCre recombinase induction, thereby preventing re-
inversion, leading to continual expression of the gene of interest (Figure S1B).  
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The advantages of this approach include: (i) the use of fewer transfection 
rounds and, consequently, fewer selectable markers when compared to the 
tetracycline-inducible system developed for L. mexicana by Kraeva and colleagues 
[10]; (ii) the possibility to induce expression of gene products from both chromosomal 
and/or episomal contexts; (iii) the system promotes a non-leaky expression that can 
be induced in a time and dosage-dependent manner; (iv) the possibility to compare 
the expression of endogenous and mutated proteins including the conditional 
expression of deleterious gene products. 
 To create the system, plasmid pGL2339 (Figure S2A) was digested and the 
array encoding the blasticidin resistance cassette and the dimerizable Cre 
recombinase subunits was integrated into the ribosomal locus to generate the 
DiCreSSU cell line (Figures 1A and Table S2). Next, the plasmid pGL2332 (Figure 
S2B) was digested and the lox66/lox77-flanked 6xHA-GFP cassette containing the 
puromycin resistance marker was integrated into the ribosomal locus of the DiCreSSU 
cell line to generate the GFPflox cell line (Figures 1B and Table S2). Both integration 
events were confirmed by PCR analysis, which also ascertained that the 6xHA-GFP 
coding sequence was present in the antisense orientation in the GFPflox cell line 
(Figure 1C). To test the system and the DiCre flipping activity, the GFPflox cell line 
was incubated with the DiCre dimerization ligand, rapamycin, and the inversion of the 
GFP cassette was confirmed by PCR analysis using the appropriate set of primers 
(Figure 1D). Semi-quantitative PCR analysis showed that the flipping reaction is time 
dependent and seem to reach its maximal level around 96 hours after induction 
(Figure S3). Importantly, flipping of the GFP cassette in the absence of rapamycin 
was not detectable in the PCR analyses shown in Figure 1D or Figure S3, indicating 
a non-leaky DiCre activity in the GFPflox cells. Upon rapamycin induction, expression 
of 6xHA-GFP was detectable after 12 hours and its levels were dose and time-
dependent (Figure 1E). Consistently, 6xHA-GFP was not detectable in the absence 
of rapamycin, further confirming the stringent regulation of the system (Figure 1E). 
We further used immunofluorescence analysis (IFA) to examine the expression 
profile within the population and observed that 6xHA-GFP was detectable by IFA only 
after rapamycin incubation (Figure 1F). Consistent with the western blot analysis, the 
IFA also demonstrated the rapamycin dose-dependence of the system (Figure S3) 
further confirmed by the quantification of GFP corresponding signal (Figure 1G). 
Besides confirming the tight regulation of the system, this set of data also 
demonstrates that the system is suitable for subcellular compartmentalization studies 
in this parasite.  
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 To expand the limits of the system we tested it for the ability to flip sequences 
from an episome, which can be found in multiple copies in the cell. To that end, the 
plasmid pGL2332 was transfected into the DiCreSSU cell line to generate the pGFPflox 
cell line (Figure 1H). PCR analysis confirmed the DiCre background and the 
presence of the target plasmid (Figure 1I), and the flipping of the 6xHA-GFP cassette 
upon rapamycin incubation (Figure 1J). Consistently, western blot analysis confirmed 
the expression of the cassette exclusively in rapamycin treated cells (Figure 1K). 
These results further demonstrate the tight control of DiCre activity and greatly 
extend the applicability of the system as a reliable tool for inducible protein 
expression not only from the genomic context, but also from episomal targets. It is 
noteworthy that this system it is not expected to be reversible, which can be a 
disadvantage if reversion of the expressed phenotype is required. However, the 
irreversibility of the system can be taken an advantageous feature to be explored in 
both in vitro and in vivo infections assays where inclusion of selection drugs and 
rapamycin might not be desired.  
 To further validate the DiCre flipping tool we used the protein Rad9, which 
participates in the Leishmania DNA Damage Response as part of the checkpoint 
clamp 9-1-1 [17,18]. In eukaryotic cells, Rad9 has an unstructured C-terminal domain 
that corresponds to ~1/3 of the protein and is necessary for its function in signalling 
genotoxic stress [19]. The unstructured C-domain of Leishmania Rad9 is ~3.5x 
longer than its human counterpart (Figure 2A) and, so far, no function has been 
reported for this C-terminal extension. To start exploring the function of this C-
terminal domain, Rad9 full length or C-terminal truncated encoding sequences, were 
cloned into the pGL6000 vector (Figure S2C), to generate the Rad9-6xHAflox and 
Rad9C’-6xHAflox cassettes, respectively. These constructs were digested and 
integrated into the ribosomal locus of the DiCreSSU cell line to generate the Rad9flox 
and Rad9C’flox cell lines, respectively (Figure 2B and Table S2). Proper Integration 
was confirmed by PCR analysis (Figure 2C) and, as expected, flipping of the 
cassettes was detected exclusively upon rapamycin incubation (Figure 2D). 
Accordingly, expression of Rad9-6xHA and Rad9C’-6xHA was detectable at 
comparable levels after induction with rapamycin, as demonstrated by western blot 
analysis (Figure 2E; upper panel). Anti-Rad9 polyclonal serum was used in western 
blot analysis to evaluate changes in total Rad9 levels (i.e. Rad9-6xHA plus 
endogenous Rad9) in the Rad9flox cell line after DiCre activation (Figure 2E; middle 
panel). Our analysis indicated that, upon induction, Rad9-6xHA was overexpressed 
when compared to the endogenous Rad9. Quantification of Rad9 signal revealed that 
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up to ~65% of the total Rad9 expressed in these cells corresponded to the induced 
version of the protein demonstrating that the system can mediate overexpression. 
Interestingly, the induction of Rad9-6xHA resulted in significant decrease in the levels 
of endogenous Rad9. However, the same effect was less pronounced when the 
truncated Rad9C’-6xHA was expressed (Figure 2E; middle panel and Figure 2F). 
These data suggest that Leishmania Rad9 levels are under tight regulation, which 
probably involves the participation of its C-terminal extension. Whether this requires 
a direct or indirect role of this domain remains to be investigated. We were not able 
to properly assess Rad9C’-6xHA levels relative to endogenous Rad9 using the 
polyclonal anti-Rad9 serum. One reason for this is that anti-Rad9 serum detects a 
faster migrating protein with the same molecular mass as Rad9C’-6xHA, hindering 
its detection. Similarly to the endogenous Rad9, the level of this protein was also 
reduced upon induction of Rad9-6xHA (Figure 2E; middle panel). While the presence 
of this band could represent cross-detection of an unrelated protein, these data 
suggest that it could be a processed form of Rad9 and further characterization is 
needed to clarify this.  
 We also analysed the effect of the deletion of the C-terminal extension on the 
Rad9 subcellular localization. Using IFA, we observed that in the majority of the cells 
Rad9-6xHA was almost exclusively found in the nuclear compartment, as previously 
described for Rad9 [17] (Figures 2G and S4). On the other hand, truncated Rad9C’-
6xHA presented a less defined localization being prominently detected in the 
cytoplasm of the majority of the cells (Figure 2G and S4). Consistently, quantitative 
analysis of the IFA data showed that Rad9-6xHA signal is concentrated in the region 
containing the nuclear DNA staining, while Rad9C’-6xHA signal expands beyond 
the nuclear staining limits (Figure 2H). Based on these data, it is reasonable to 
conclude that the C-terminal extension is necessary for proper subcellular distribution 
of Rad9 in Leishmania.   
 In summary, we have demonstrated that the DiCre-based expression system 
described here is a valuable addition to the Leishmania genetic manipulation toolkit. 
Its use to study the parasite Rad9 revealed important features of the protein, 
produced reagents for future studies and proved its value for functional analyses in 
this parasite. 
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Legends to Figures 
 
Figure 1. Establishment of an inducible DiCre-based expression system in L. 
major. (A) Schematic representation (not in scale) of the cassette encoding the 
truncated forms of DiCre after integration into the 18S ribosomal RNA locus (SSU) of 
L. major wild type cell (LT252) to generate the DiCreSSU cell line; BLA: blasticidin 
resistance marker. (B) Schematic representation (not in scale) of the 6xHA-GFP 
cassette (see Figure S1B for details) after integration into the SSU locus of the 
DiCreSSU cell line (A) to generate the GFPflox cell line; PAC: puromycin resistance 
marker; upon rapamycin (RAP) addition, the indicated lox sites mediate the flipping of 
6xHA-GFP cassette allowing its expression. In (A) and (B), black arrows indicate 
approximate annealing position of primers used for PCR analysis. (C) PCR analysis 
of genomic DNA (gDNA) using the indicated set of primers (annealing positions 
shown in (A) and (B)); DHFR-TS was the loading control for all PCR analyses 
presented in this work. (D) PCR analysis of gDNA from GFPflox cells cultivated in the 
presence (+) or absence (-) of 100nM RAP for 48h; primers are indicated below each 
panel (see annealing positions in (B)). (E) Western blot analysis of total cell extracts 
from the GFPflox cells cultivated with RAP for the indicated periods of time; two 
distinct cell-equivalent amount of extracts was analysed; anti-HA was used to detect 
6xHA-GFP; EF1 was the loading control. (F) Immunofluorescence analysis of 
GFPflox cells cultivated in the presence (+) or absence (-) of 100nM RAP for 48h; 
images were acquired with a DMI 6000B inverted microscope (Leica); n and k 
indicate nuclear and kinetoplast DNA, respectively; scale bar = 5m. (G) GFPflox cells 
were subject to immunofluorescence as in (F) after cultivation with RAP for 48h; 
signal corresponding to 6xHA-GFP from individual cells was quantified using Image J 
software; bars indicate mean +/- Standard Deviation (S.D.); p values by Kruskal-
Wallis test were: (**) = 0.0057; (***) = 0.0008. (H) The plasmid pGL2332 (Figure 
S1B) was transfected as a circular episome in the DiCreSSU cells to generate the 
pGFPflox cell line; as in (B), RAP addition is expected to induce expression of 6xHA-
GFP; schematic representations are not in scale. (I) PCR analysis of gDNA using the 
indicated set of primers (annealing positions shown in (A) and (H). (J) PCR analysis 
of gDNA from pGFPflox cells cultivated in the presence (+) or absence (-) of 100nM 
RAP for 48h; primers are indicated below each panel (see annealing position in (H)). 
(K) Western blot analysis of total cell extracts from the pGFPflox cells cultivated in the 
presence (+) or absence (-) of 100nM RAP for 48h; anti-HA was used to detect 
6xHA-GFP; EF1 was the loading control. 
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Figure 2. Expression of Rad9 and Rad9C’ using the DiCre-based inducible 
system. (A) Predicted amino acid sequence of Rad9 from L. major (LmjF.15.0980) 
and Homo sapiens (NP_004575.1) were subject to disorder prediction using IUPred 
(http://iupred.enzim.hu); values above 0.5 (horizontal black dotted line) can be 
considered as disordered regions; horizontal grey bars above each graph indicate 
the Rad9 domain (Pfam: PF04139) and the disordered C-terminal domain; C-terminal 
domain of human Rad9 and the corresponding region in L. major Rad9 is indicated 
as C; the extended C-terminal of L. major Rad9 is indicated as C’. (B) Full length 
Rad9 from L. major or a truncated version lacking the C-terminal extension (C’), were 
cloned as C-terminal fusion with a 6xHA tag to generated the Rad9-6xHAflox and 
Rad9C’-6xHAflox constructs (not in scale); Rad9-6xHA and Rad9C’-6xHA 
constructs are arranged in an inverted orientation, flanked by the indicated lox 
sequences and were integrated into the ribosomal locus (SSU) of the DiCreSSU cells 
(see Figure 1A) to generate the Rad9flox and Rad9C’flox cell lines, respectively; black 
arrows indicate approximate annealing position of oligonucleotides used for PCR 
analyses; PAC: puromycin resistance marker. (C) PCR analysis of gDNA using the 
indicated set of primers (see annealing positions in (B)). (D) PCR analysis of gDNA 
from cells cultivated in the presence (+) or absence (-) of 100nM RAP for 48h; 
primers are indicated below each panel (see annealing positions in (B)). (E)  
Western blot analysis of total cell extracts from the indicated cells cultivated in the 
presence (+) or absence (-) of RAP for 48 hours; anti-HA (upper panel) and anti-
Rad9 (bottom panel) was used to detect Rad9-6xHA Rad9C’-6xHA; a protein with a 
similar migration pattern of Rad9C’-6xHA is detected by anti-Rad9 and is indicated 
with (*); GAPDH was the loading control. (F) Levels of endogenous Rad9 in western 
blot analysis shown in (E) were determined and normalized with the GAPDH signal, 
using Image J software; signal from cells exposed to RAP was plotted as a fraction 
relative to signal from respective non-induced culture. (G) Immunofluorescence 
analysis of the indicated cells cultivated in the presence (+) or absence (-) of 100nM 
RAP for 48h; images are representative of a Z-maximal projection from 14 Z-slices 
acquired with a multiphoton system coupled with LMS780 AxioObserver microscope 
(Zeiss); n and k indicate nuclear and kinetoplast DNA, respectively; black bars on the 
DIC field indicate the section where quantification shown in (H) was performed; n and 
k indicate nuclear and kinetoplast DNA, respectively; scale bar (white) = 5m. (H) 
Signal corresponding to DAPI, Rad9-6xHA and Rad9C’-6xHA  in the section 
indicated by the black bar in (G) was quantified with ImageJ. 
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